A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
2013 · The Journal of Experimental Medicine · 935 citations
https://doi.org/10.1084/jem.20130351
M
Maryam Salimi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
4.3K
Citations
25
h-index
29
i10-index
Maryam Salimi is an academic researcher from University of Oxford. The author has contributed to research in topics: IL-33, ST2, and ILC Pathways & Eosinophilic Esophagitis & Dermatology and Skin Diseases. The author has an h-index of 25, co-authored 31 publications.
ORCID: 0000-0003-3618-6313Papers by this author
worksSpontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity
2015 · Journal of Allergy and Clinical Immunology · 159 citations
https://doi.org/10.1016/j.jaci.2015.06.045
Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines
2017 · Journal of Allergy and Clinical Immunology · 152 citations
https://doi.org/10.1016/j.jaci.2016.12.958
Serum IL-10 as a marker of severe dengue infection
2013 · BMC Infectious Diseases · 112 citations
https://doi.org/10.1186/1471-2334-13-341
Activated innate lymphoid cell populations accumulate in human tumour tissues
2018 · BMC Cancer · 105 citations
https://doi.org/10.1186/s12885-018-4262-4
Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk
2014 · Journal of Allergy and Clinical Immunology · 68 citations
https://doi.org/10.1016/j.jaci.2014.09.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat